Based on Decision Resources' U.S. Physician & Payer Forum report entitled Hospital Anti-Infectives: Insights on the Uptake, Formulary Inclusion, and Reimbursement of Emerging Antibiotics in the U.S. and our Hospital Insight Series: Hospital Anti-Infectives report, Decision Resources, Inc. is offering this exclusive webinar.
Date & Time
Recorded live on Wednesday, June 1, 2011
This webinar, presented by Decision Resources Analyst Charu Vepari, Ph.D., will answer the following questions:
- What are the leading indications, patient comorbidities and patient risk factors in the hospital anti-infectives market? With regard to treatment intent—empiric, confirmed/documented or prophylaxis—how is the patient population segmented?
- What percent of infections are due to key gram-positive and gram-negative pathogens? Who are the key prescribers in the hospital setting with respect to cost, patient share and days of therapy?
- Are there differences among infectious disease specialists and internists in their concern regarding current treatments available for key pathogens? What is the preferred first-line treatment for suspected and confirmed MRSA and gram-negative infections? How common is compounding of IV vancomycin for oral administration in patients with infections caused by C. difficile?
- What do clinicians consider to be the top three most difficult-to-treat indications for MRSA and gram-negative infections? What are the attributes clinicians look for in a drug for the treatment of these infections? How do clinicians anticipate using key emerging therapies for infections caused by C. difficile, MRSA and gram-negative pathogens?
- Who are the individuals with the greatest influence on hospital antibiotic formulary decisions and what are the most influential factors in the formulary inclusion of an antibiotic? What factors are the most important to pharmacy directors for assessing cost of antibiotic therapy and which measures do pharmacy directors consider in their decision for cost-effectiveness analysis?
This webinar was held on June 1, 2011.
Contact us to learn how you can purchase both of these reports and access the recorded event.
Click here to view the invite.